ocrelizumab and hyaluronidase
ocrelizumab and hyaluronidase is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Ocrevus Zunovo. Available dosage form: injection, solution.
Drug details
- Generic Name
- ocrelizumab and hyaluronidase
- Brand Names
- Ocrevus Zunovo
- Application Number
- BLA761371
- Sponsor
- Genentech, Inc.
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- OCRELIZUMAB, HYALURONIDASE (HUMAN RECOMBINANT)